Molecular Pathogenesis of NASH
AbstractNonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world and a major health problem, owing to its close association with obesity, diabetes, and the metabolic syndrome. NASH progression results from numerous events originating within the liver, as well as from signals derived from the adipose tissue and the gastrointestinal tract. In a fraction of NASH patients, disease may progress, eventually leading to advanced fibrosis, cirrhosis and hepatocellular carcinoma. Understanding the mechanisms leading to NASH and its evolution to cirrhosis is critical to identifying effective approaches for the treatment of this condition. In this review, we focus on some of the most recent data reported on the pathogenesis of NASH and its fibrogenic progression, highlighting potential targets for treatment or identification of biomarkers of disease progression. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Caligiuri, A.; Gentilini, A.; Marra, F. Molecular Pathogenesis of NASH. Int. J. Mol. Sci. 2016, 17, 1575.
Caligiuri A, Gentilini A, Marra F. Molecular Pathogenesis of NASH. International Journal of Molecular Sciences. 2016; 17(9):1575.Chicago/Turabian Style
Caligiuri, Alessandra; Gentilini, Alessandra; Marra, Fabio. 2016. "Molecular Pathogenesis of NASH." Int. J. Mol. Sci. 17, no. 9: 1575.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.